DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Position Increased by Geode Capital Management LLC

Geode Capital Management LLC increased its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 1.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,612,370 shares of the medical instruments supplier's stock after buying an additional 64,542 shares during the period. Geode Capital Management LLC owned about 1.82% of DENTSPLY SIRONA worth $68,584,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Riverview Trust Co acquired a new stake in DENTSPLY SIRONA in the fourth quarter valued at $26,000. MassMutual Private Wealth & Trust FSB increased its holdings in DENTSPLY SIRONA by 648.4% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock valued at $27,000 after acquiring an additional 1,232 shares in the last quarter. UMB Bank n.a. raised its position in DENTSPLY SIRONA by 60.8% during the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock worth $28,000 after acquiring an additional 564 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in shares of DENTSPLY SIRONA by 700.0% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier's stock valued at $33,000 after purchasing an additional 1,568 shares in the last quarter. Finally, Signaturefd LLC grew its position in shares of DENTSPLY SIRONA by 513.3% in the fourth quarter. Signaturefd LLC now owns 4,428 shares of the medical instruments supplier's stock valued at $84,000 after purchasing an additional 3,706 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Stock Up 1.4 %

NASDAQ:XRAY traded up $0.18 on Friday, reaching $12.83. The stock had a trading volume of 2,841,795 shares, compared to its average volume of 2,953,364. The company has a 50-day moving average of $15.72 and a 200 day moving average of $18.82. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The stock has a market cap of $2.56 billion, a P/E ratio of -6.20, a price-to-earnings-growth ratio of 1.80 and a beta of 0.92. DENTSPLY SIRONA Inc. has a 12-month low of $12.16 and a 12-month high of $31.00.

DENTSPLY SIRONA Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were paid a dividend of $0.16 per share. The ex-dividend date was Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a yield of 4.99%. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -14.07%.

Insiders Place Their Bets

In related news, Director Gregory T. Lucier purchased 15,142 shares of the business's stock in a transaction that occurred on Monday, March 3rd. The shares were purchased at an average cost of $16.51 per share, with a total value of $249,994.42. Following the completion of the acquisition, the director now directly owns 81,971 shares of the company's stock, valued at approximately $1,353,341.21. The trade was a 22.66 % increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.52% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on XRAY shares. Evercore ISI reissued an "in-line" rating and issued a $20.00 price target on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. Jefferies Financial Group downgraded shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating and lowered their price target for the stock from $30.00 to $20.00 in a report on Thursday, January 23rd. StockNews.com cut shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research note on Friday, February 28th. Barrington Research lowered their price objective on DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating for the company in a research report on Friday, February 28th. Finally, Robert W. Baird decreased their price target on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a research note on Friday, February 28th. Thirteen analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $22.58.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.